Dengue-induced immunity differentially neutralizes closely related ZIKV strains, with generally stronger activity against P6-740, suggesting that viral genetic variation may influence cross-neutralization outcomes.
Abstract
Background: Zika virus (ZIKV) and dengue virus (DENV) co-circulate in tropical regions and elicit cross-reactive immunity. However, differential neutralization of closely related ZIKV strains remains unclear. This study characterizes the neutralization profiles of dengue-immune sera against DENV and two Asian-lineage ZIKV strains, P6-740 and PRVABC59. Methods: Sera from suspected dengue infections and from healthy donors were screened for anti-DENV IgM and IgG antibodies and anti-ZIKV IgM and IgG antibodies by ELISA and grouped. Neutralization against DENV serotypes and two ZIKV strains was quantified using the foci reduction neutralization test (FRNT). Complete genome sequences of ZIKV P6-740 and PRVABC59 were compared to identify amino acid differences. Results: Sera containing anti-DENV IgG showed higher neutralizing activity against both DENV and ZIKV than IgG-negative sera. Neutralization was also detected in some ELISA-seronegative samples. Across all immunological groups, neutralization titers were higher against ZIKV P6-740 than ZIKV PRVABC59. Among healthy donors with evidence of previous dengue exposure, 58% exhibited a ≥4-fold difference between the two ZIKV strains, of which 80% favored ZIKV P6-740. Among seronegative healthy blood donors, 45% exhibited a 4-fold difference, of which 89% favored P6-740. Four amino acid substitutions were identified in the envelope (E) protein. Conclusions: Dengue-induced immunity differentially neutralizes closely related ZIKV strains, with generally stronger activity against P6-740, suggesting that viral genetic variation may influence cross-neutralization outcomes.
Accurate diagnostics of dengue virus (DENV) infection are essential for patient management, outbreak control, and vaccine implementation. Serological testing plays a key role, especially when molecular assays are unavailable or viremia subsides; yet, cross-reactivity with other flaviviruses remains a challenge. T...
J. Weiss, S. Saschenbrecker, Nadja Muigg et al.· Clinical Chemistry· 0 citations
Pre-existing Orthoflavivirus immunity can shape antibody recall upon infection with a heterologous virus. We monitored Zika virus (ZIKV) infection in individuals vaccinated against yellow fever virus (YFV), with or without prior dengue virus (DENV) exposure. We obtained longitudinal serology data (NS1- and whole-virus...
S. Marquine, N. Ayhan, K. M. Meneyrol et al.· medRxiv· 0 citations
A highly specific blocking ELISA was developed for serological diagnosis of porcine epidemic diarrhea (PED) using monoclonal antibodies (mAbs) against the S1 protein of PEDV. The S1 protein was expressed in HEK293F cells and used to immunize BALB/c mice. Through hybridoma screening, a high-affinity monoclonal antibody...
Pei-Yang Ding, Shuo-Qi Dong, Lin-Yi Bai et al.· Veterinary research communic...· 0 citations
Findings provide updated evidence of DENV and CHIKV exposure in macaques at the human–wildlife interface and highlight the need for integrated longitudinal surveillance of NHPs, mosquito vectors, and humans to better understand arbovirus ecology and transmission dynamics.
J. John, M. M. Ngwe Tun, Merveille Kapandji et al.· Tropical Medicine and Health· 0 citations
Background: Dengue is a major mosquito-borne viral disease worldwide, with approximately 400 million infections reported annually and no fully effective antiviral treatments available. The non-structural protein NS5 is a promising antiviral target due to its critical role in viral RNA replication and host interactions....
Liliana Morales, C. Bueno Angarita, M. Calderón-Peláez et al.· Avicenna journal of medical...· 0 citations
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.